Ocular input for human melatonin regulation: Relevance to breast cancer

Neuroendocrinology Letters

Volumn 23, Issue SUPPL. 2, 2002, Pages 17-22

  Glickman, Gena ^a   Levin, Robert ^a   Brainard, George C ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Action spectrum; Cancer; Circadian; Light; Melatonin; Photoreceptor

Indexed keywords

MELATONIN; RETINOL;

ARTICLE; BLINDNESS; BREAST CANCER; CANCER RISK; CIRCADIAN RHYTHM; CONTROLLED STUDY; FEMALE; HOMEOSTASIS; HORMONAL REGULATION; HORMONE INHIBITION; HUMAN; IN VITRO STUDY; INDUSTRIALIZATION; LIGHT EXPOSURE; NIGHT; NONHUMAN; PHOTOSENSITIVITY; PHOTOSTIMULATION; PREVALENCE; SENSORY STIMULATION; SHIFT WORKER; SPECTRUM; VISION; VISUAL SYSTEM FUNCTION;

EID: 0036331966     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Electric power use and breast cancer: A hypothesis
2. Light in the built environment: Potential role of circadian disruption in endocrine disruption and breast cancer
3. Photic regulation of melatonin in humans: Ocular and neural signal transduction
4. Melatonin and the pineal gland: Influence on mammalian seasonal and circadian physiology
5. The validity of melatonin as an oncostatic agent
6. Melatonin as a chronobiotic/anticancer agent: Cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy
7. Stage-dependent depression of melatonin in patients with primary breast cancer
8. Serial transplants of DMBA-induced mammary tumours in Fischer rats as model system for human breast cancer. II. Analysis of pineal melatonin biosynthesis and secretion
9. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz[a]anthracene-induced mammary tumors in the rat
10. Pineal ablation in varying photoperiods and the incidence of 9,10-dimethyl-1,2-benzanthracene induced mammary cancer in rats
11. Light contamination during the dark phase in "photoperiodically controlled" animal rooms: Effect on tumor growth and metabolism in rats
12. Dim light during darkness stimulates tumor progression by enhancing tumor fatty acid uptake and metabolism
13. Effect of melatonin on mammary carcinogenesis in intact and pinealectomized rats in varying photoperiods
14. Physiological melatonin inhibition of human breast cancer cell growth in vitro: Evidence for a glutathione-mediated pathway
15. Melatonin does not inhibit estradiol-stimulated proliferation in MCF-7 and BG-1 cells
16. Melatonin blocks the activation of estrogen receptor for DNA binding
17. Elevated serum estradiol and testsoterone concentrations are associated with a high risk for breast cancer
18. Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events
19. Profound bilateral blindness and the incidence of breast cancer
20. Reduced cancer incidence among the blind
21. Inverse association between breast cancer incidence and degree of visual impairment in Finland
22. Risk of breast cancer among Norwegian women with visual impairment
23. Increased breast cancer risk among women who work predominantly at night
24. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study
25. Night shift work, light at night, and risk of breast cancer
26. Does winter darkness in the Arctic protect against cancer? The melatonin hypothesis revisited
27. Pineal gland: Interface between the photoperiodic environment and the endocrine system
28. The retinohypothalamic tract originates from a distinct subset of retinal ganglion cells
29. Action spectrum for melatonin regulation in humans: Evidence for a novel circadian photoreceptor
30. Nocturnal elevation of plasma melatonin and urinary 5-hydroxyindoleacetic acid in young men: Attempts at modification by brief changes in environmental lighting and sleep by autonomic drugs
31. Urinary melatonin rhythms during sleep deprivation in depressed patients and normaLs
32. Entrainment of rhythmic melatonin secretion in man to a 12-hour phase shift in the light/dark cycle
33. Melatonin in humans: Physiological and clinical studies
34. Light suppresses melatonin secretion in humans
35. Retinohypothalamic pathway: A breach in the law of Newton-Muller-Gudden
36. Visual projections to the rodent hypothalamus
37. Pupil size regulation of threshold of light-induced melatonin suppression
38. Bright light induction of strong (Type 0) resetting of the human circadian pacemaker
39. The suppression of pineal melatonin content and N-acetyltransferase activity by different light irradiances in the Syrian hamster: A dose-response relationship
40. Sensitivity of the human circadian pacemaker to nocturnal light: Melatonin phase resetting and suppression
41. Comparison of visual sensitivity for suppression of pineal melatonin and circadian phase-shifting in the golden hamster
42. Spectral sensitivity of a novel photoreceptive system mediating entrainment of mammalian circadian rhythms
43. Melatonin rhythm is not shifted by lights that suppress nocturnal melatonin in humans under entrainment
44. Bright light resets the human circadian pacemaker independent of the timing of the sleep-wake cycle
45. Antidepressant and circadian phase-shifting effects of light
46. Dose-response relationships for resetting of human circadian clock by light
47. Light of domestic intensity produces phase shifts of the circadian oscillators in humans
48. Human melatonin regulation is not mediated by the three cone photopic visual system
49. An action spectrum for melatonin suppression: Evidence for a novel non-rod, non-cone photoreceptor system in humans
50. Intrinsic near-24-h pacemaker period determines limits of circadian entrainment to a weak synchronizer in humans
51. A new template for rhodopsin (vitamin A1 based) visual pigments
52. The primary visual pathway in humans is regulated according to long-term light exposure through the action of a nonclassical photopigment
53. Characterization of an ocular photopigment capable of driving pupillary constriction in mice
54. Phototransduction by retinal ganglion cells that set the circadian clock
55. A novel and ancient vertebrate opsin
56. Encephalopsin: A novel mammalian extra-retinal opsin discretely localized in the brain
57. Vitamin B2-based blue-light photorpceptors in the retinohypothalamic tract as the photoactive pigments for setting the circadian clock in mammals
58. Retinal projections in mice with inherited retinal degeneration: Implications for circadian photoentrainmnet
59. A novel human opsin in the inner retina
60. Melanopsin in cell of origin of the retinohypothalamic tract
61. The photopigment melanopsin is exclusively present in pituitary adenylate cyclase-activating polypeptide-containing retinal ganglion cells of the retinohypothalamic tract
62. Photoreceptive net in the mammalian retina
63. Metanopsin-containing retinal ganglion cells: Architecture, projections, and intrinsic photosensitivity